Development of a Hematology-General Medicine Hybrid Team to Improve Care of Patients With Sickle Cell Disease.
Saved in:
| Title: | Development of a Hematology-General Medicine Hybrid Team to Improve Care of Patients With Sickle Cell Disease. |
|---|---|
| Authors: | Merz LE; L.E. Merz is a hematology/oncology fellow, Dana-Farber Cancer Center, Boston, Massachusetts., Osei MA; M.A. Osei is a hematology/oncology fellow, Dana-Farber Cancer Center, Boston, Massachusetts; mkwarteng-siaw@bwh.harvard.edu., Green A; A. Green is a resident physician, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts; agreen22@bwh.harvard.edu., Story CM; C.M. Story is a hematology fellow, Johns Hopkins Hospital, Baltimore, Maryland; cmstory@bwh.harvard.edu., Schuering KM; K.M. Schuering is assistant professor of medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts; kelly.schuering@gmail.com., Achebe MO; M.O. Achebe is clinical director of nonmalignant hematology, Division of Hematology, Brigham and Women's Hospital, Boston, Massachusetts; machebe@bwh.harvard.edu. |
| Source: | Academic medicine : journal of the Association of American Medical Colleges [Acad Med] 2024 Jun 01; Vol. 99 (6), pp. 618-622. Date of Electronic Publication: 2024 Feb 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Published for the Association of American Medical Colleges by Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8904605 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-808X (Electronic) Linking ISSN: 10402446 NLM ISO Abbreviation: Acad Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
